|
Market Closed -
Oslo Bors
09:15:00 06/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.5200 NOK | +1.96% |
|
-6.81% | -87.91% |
| 13/10 | Induct AS Expands Scope of Existing Severe Asthma Care Pathway | CI |
| 13/08 | Induct AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Induct
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 134.6 | 25.21 | - | - |
| Change | - | -81.27% | - | - |
| Enterprise Value (EV) 1 | 134.6 | 21.61 | 29.91 | 33.81 |
| Change | - | -83.95% | 38.4% | 13.04% |
| P/E | - | -2.08x | -3.47x | -17.3x |
| PBR | - | - | - | - |
| PEG | - | - | 0.1x | 0.2x |
| Capitalization / Revenue | 8.12x | 1.76x | 1.53x | 1.02x |
| EV / Revenue | 8.12x | 1.51x | 1.81x | 1.37x |
| EV / EBITDA | - | 6x | 4.53x | 2.64x |
| EV / EBIT | - | -2.43x | -4.99x | 338x |
| EV / FCF | - | -5.4x | -7.48x | -33.8x |
| FCF Yield | - | -18.5% | -13.4% | -2.96% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | -0.25 | -0.15 | -0.03 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 16.58 | 14.3 | 16.5 | 24.6 |
| EBITDA 1 | - | 3.6 | 6.6 | 12.8 |
| EBIT 1 | - | -8.9 | -6 | 0.1 |
| Net income 1 | -7.14 | -9.9 | -7.2 | -1.5 |
| Net Debt 1 | - | -3.6 | 4.7 | 8.6 |
| Reference price 2 | 4.3000 | 0.5200 | 0.5200 | 0.5200 |
| Nbr of stocks (in thousands) | 31,309 | 48,489 | - | - |
| Announcement Date | 12/02/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 1.48x | 5.87x | - | 26.62L | ||
| 26.89x | 10.02x | 16.23x | 0.74% | 3,98000Cr | ||
| 92.49x | 42.23x | 68.06x | -.--% | 37TCr | ||
| 17.26x | 5.25x | 9.11x | 1.78% | 36TCr | ||
| 29.85x | 6.1x | 18.97x | 1.25% | 28TCr | ||
| 199.65x | 17.7x | 51.82x | -.--% | 26TCr | ||
| 1866.62x | 36.23x | 118.53x | -.--% | 22TCr | ||
| 22.83x | 14.45x | 17.22x | -.--% | 12TCr | ||
| 71.62x | 6.54x | 17.14x | -.--% | 11TCr | ||
| 13.51x | 3.59x | 7.51x | -.--% | 9.59TCr | ||
| Average | 260.08x | 14.36x | 33.05x | 0.42% | 57.92TCr | |
| Weighted average by Cap. | 109.64x | 12.88x | 24.67x | 0.68% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- INDCT Stock
- Valuation Induct
Select your edition
All financial news and data tailored to specific country editions
















